Archive for September, 2016

You can take the Israeli out of Israel, but you can’t dampen his entrepreneurial spirit. Dr. Amir Lerman, a Technion graduate of The Ruth and Bruce Rappaport Faculty of Medicine (class of ‘85), is leading an initiative at the Mayo Clinic to promote collaboration with Israeli startups for medical innovation.

Dr Lerman2

Dr. Lerman at his research laboratory at Mayo Clinic

The Mayo Clinic Israeli Startups Initiative, announced in May during the IATI-Biomed 2016 conference, will partner, collaborate with and invest in Israeli medical technology with the aim of accelerating the availability of medical innovations. “Israel is very innovative in the field of biomedical research. So engagement with early or late stage medical companies will benefit our patients in the long run,” says Dr. Lerman, a cardiologist and the medical director of the Rochester, Minnesota-based Mayo Clinic Initiative.


3545761_0005 (Electronic Presentation)

Dr. Lerman at his Cardiac Catherization laboratory at Mayo Clinic

The plan is to partner and collaborate with startups, institutions and researchers, as well as venture capital firms, to develop promising technology across a variety of areas including therapy, diagnostics, prognostics, devices, individualized medicine and regenerative medicine. “We are not restricting ourselves. We are looking for good technologies.”

The initiative is a win-win situation, as Mayo improves its treatment options and Israeli startups are helped to penetrate the U.S. market. “It’s also important to show that a major medical institution in the U.S. chose to work with start-up companies from Israel,” says Lerman.

Dr. Lerman was born and raised in Israel, and graduated from the Technion School of Medicine (cum laude) in 1985, before completing his training in Internal Medicine, Cardiovascular Diseases and Invasive Cardiology at the Mayo Clinic. “Studying at the Technion Medical School was a great experience,” he recalls. “The first year or more we studied together with the engineering school, which had a major effect on how I look at things in medicine.”

The Startups Initiative is managed by Mayo Clinic Ventures, the commercialization arm of the Mayo Clinic, and supported in part by The Merage Institute, which is committed to promoting trade as a vehicle to economic growth between Israel and the United States.

For more information, contact Dr. Amir Lerman at lerman.amir@mayo.edu.



Read Full Post »